Lexicon Pharmaceuticals | LXRX - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Abbott 24.94 5.78 2026-03
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
Akebia Therapeutics 1.63K 1.6K 2025-12
Alnylam Pharmaceuticals 80.04 90.66 2026-03
AstraZeneca 29.59 2.3 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Eli Lilly 40.27 0.06 2026-03
Esperion Therapeutics 129.79 129 2024-12
Halozyme Therapeutics 11.35 11.8 2026-03
Illumina 32.45 2.07 2026-03
Ironwood Pharmaceuticals 204.24 88.19 2024-12
J&J 24.53 0.91 2026-03
Lexicon Pharmaceuticals 12.44 4.73 2021-06
MannKind 201.15 102.55 2026-03
Merck 16.52 2.6 2026-03
Moderna 27.22 14.51 2023-06
Novartis 20.17 2.32 2026-03
PTC Therapeutics 9.98 3.25 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Sarepta Therapeutics 27.27 0 2025-12
Thermo Fisher Scientific 27.71 3.29 2026-03
United Therapeutics 20.42 3.1 2026-03
Vanda Pharmaceuticals 16.79 7.07 2023-06